RSNA 2023 showcased Koning Health’s groundbreaking Koning Vera Breast CT, revolutionizing breast cancer detection with its unparalleled 3D imaging and biopsy capabilities. The event underscored the urgency for early cancer detection, emphasizing KBCT’s ability…
Continue Reading
The UEF Cancer AI team launched a challenge for estimating breast density from mammograms. Addressing limitations in existing tools, the challenge seeks innovative deep-learning architectures. Participants work with a dataset of 569 mammogram images,…
Continue Reading
By Shania Kennedy
November 30, 2023 – Researchers from Northwestern University have developed an artificial intelligence (AI) tool that may be able to spare breast cancer patients unnecessary chemotherapy treatments by using cell patterns to predict…
Continue Reading
GE HealthCare launched a new AI suite this week at RSNA 2023, the annual radiology and medical imaging conference in Chicago. The new product, called the MyBreastAI suite, is designed to simplify radiologists’ workflows…
Continue Reading
It is uncommon for risk groups defined by statistical or artificial intelligence (AI) models to be chosen by jointly considering model performance and potential interventions available. We develop a framework to rapidly guide choice…
Continue Reading
While breast cancer garners widespread attention, mental health awareness often lingers in the shadows when compared to other medical conditions. The two diseases stand at opposite ends of the spectrum of diagnosis, treatment and…
Continue Reading
iCAD and CancerIQ have united to create an advanced breast healthcare solution. Their partnership merges iCAD’s AI-driven ProFound Breast Health Suite with CancerIQ’s precision platform, enhancing breast cancer risk prediction and personalized care plans….
Continue Reading
AI’s impact on healthcare unfolds through HEALWELL AI’s acquisition of Pentavere, fortifying data-driven diagnostics. Forward Health introduces CarePods, reshaping accessibility to comprehensive medical services. Lunit’s FDA clearance for breast cancer detection highlights AI’s pivotal…
Continue Reading
At RSNA 2023, Lunit will display seven AI studies aimed at enhancing diagnostic efficiency in chest radiography and breast cancer risk evaluation. The presentations will showcase advancements like AI algorithms that improve the accuracy…
Continue Reading
Paige, a global leader in digital pathology solutions, has received the FDA’s Breakthrough Device Designation for Paige Lymph Node. This AI application is a pioneering tool for detecting breast cancer metastases in lymph nodes….
Continue Reading
